Global Opioids Drug Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-opioids-drug-market-research-report-2022status-n-outlook_en.gif)
Report Overview:
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The Global Opioids Drug Market Size was estimated at USD 9874.44 million in 2023 and is projected to reach USD 8854.86 million by 2029, exhibiting a CAGR of -1.80% during the forecast period.
This report provides a deep insight into the global Opioids Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Opioids Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Opioids Drug market in any manner.
Global Opioids Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Market Segmentation (by Type)
Oxycodone
Hydromorphone
Codeine
Fentanyl
Market Segmentation (by Application)
Pain Relief
Anesthesia
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioids Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The Global Opioids Drug Market Size was estimated at USD 9874.44 million in 2023 and is projected to reach USD 8854.86 million by 2029, exhibiting a CAGR of -1.80% during the forecast period.
This report provides a deep insight into the global Opioids Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Opioids Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Opioids Drug market in any manner.
Global Opioids Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Market Segmentation (by Type)
Oxycodone
Hydromorphone
Codeine
Fentanyl
Market Segmentation (by Application)
Pain Relief
Anesthesia
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Opioids Drug Market
- Overview of the regional outlook of the Opioids Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioids Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Opioids Drug
1.2 Key Market Segments
1.2.1 Opioids Drug Segment by Type
1.2.2 Opioids Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OPIOIDS DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Opioids Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Opioids Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OPIOIDS DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Opioids Drug Sales by Manufacturers (2019-2024)
3.2 Global Opioids Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Opioids Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Opioids Drug Sales Sites, Area Served, Product Type
3.6 Opioids Drug Market Competitive Situation and Trends
3.6.1 Opioids Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Opioids Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OPIOIDS DRUG INDUSTRY CHAIN ANALYSIS
4.1 Opioids Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OPIOIDS DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OPIOIDS DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioids Drug Sales Market Share by Type (2019-2024)
6.3 Global Opioids Drug Market Size Market Share by Type (2019-2024)
6.4 Global Opioids Drug Price by Type (2019-2024)
7 OPIOIDS DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioids Drug Market Sales by Application (2019-2024)
7.3 Global Opioids Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Opioids Drug Sales Growth Rate by Application (2019-2024)
8 OPIOIDS DRUG MARKET SEGMENTATION BY REGION
8.1 Global Opioids Drug Sales by Region
8.1.1 Global Opioids Drug Sales by Region
8.1.2 Global Opioids Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Opioids Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Opioids Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Opioids Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Opioids Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Opioids Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva
9.1.1 Teva Opioids Drug Basic Information
9.1.2 Teva Opioids Drug Product Overview
9.1.3 Teva Opioids Drug Product Market Performance
9.1.4 Teva Business Overview
9.1.5 Teva Opioids Drug SWOT Analysis
9.1.6 Teva Recent Developments
9.2 Purdue Pharma
9.2.1 Purdue Pharma Opioids Drug Basic Information
9.2.2 Purdue Pharma Opioids Drug Product Overview
9.2.3 Purdue Pharma Opioids Drug Product Market Performance
9.2.4 Purdue Pharma Business Overview
9.2.5 Purdue Pharma Opioids Drug SWOT Analysis
9.2.6 Purdue Pharma Recent Developments
9.3 Mallinckrodt
9.3.1 Mallinckrodt Opioids Drug Basic Information
9.3.2 Mallinckrodt Opioids Drug Product Overview
9.3.3 Mallinckrodt Opioids Drug Product Market Performance
9.3.4 Mallinckrodt Opioids Drug SWOT Analysis
9.3.5 Mallinckrodt Business Overview
9.3.6 Mallinckrodt Recent Developments
9.4 Amneal Pharma
9.4.1 Amneal Pharma Opioids Drug Basic Information
9.4.2 Amneal Pharma Opioids Drug Product Overview
9.4.3 Amneal Pharma Opioids Drug Product Market Performance
9.4.4 Amneal Pharma Business Overview
9.4.5 Amneal Pharma Recent Developments
9.5 Collegium
9.5.1 Collegium Opioids Drug Basic Information
9.5.2 Collegium Opioids Drug Product Overview
9.5.3 Collegium Opioids Drug Product Market Performance
9.5.4 Collegium Business Overview
9.5.5 Collegium Recent Developments
9.6 JandJ
9.6.1 JandJ Opioids Drug Basic Information
9.6.2 JandJ Opioids Drug Product Overview
9.6.3 JandJ Opioids Drug Product Market Performance
9.6.4 JandJ Business Overview
9.6.5 JandJ Recent Developments
9.7 Endo
9.7.1 Endo Opioids Drug Basic Information
9.7.2 Endo Opioids Drug Product Overview
9.7.3 Endo Opioids Drug Product Market Performance
9.7.4 Endo Business Overview
9.7.5 Endo Recent Developments
9.8 Pfizer
9.8.1 Pfizer Opioids Drug Basic Information
9.8.2 Pfizer Opioids Drug Product Overview
9.8.3 Pfizer Opioids Drug Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 INSYS
9.9.1 INSYS Opioids Drug Basic Information
9.9.2 INSYS Opioids Drug Product Overview
9.9.3 INSYS Opioids Drug Product Market Performance
9.9.4 INSYS Business Overview
9.9.5 INSYS Recent Developments
9.10 Mylan
9.10.1 Mylan Opioids Drug Basic Information
9.10.2 Mylan Opioids Drug Product Overview
9.10.3 Mylan Opioids Drug Product Market Performance
9.10.4 Mylan Business Overview
9.10.5 Mylan Recent Developments
9.11 Hikma
9.11.1 Hikma Opioids Drug Basic Information
9.11.2 Hikma Opioids Drug Product Overview
9.11.3 Hikma Opioids Drug Product Market Performance
9.11.4 Hikma Business Overview
9.11.5 Hikma Recent Developments
9.12 Egalet
9.12.1 Egalet Opioids Drug Basic Information
9.12.2 Egalet Opioids Drug Product Overview
9.12.3 Egalet Opioids Drug Product Market Performance
9.12.4 Egalet Business Overview
9.12.5 Egalet Recent Developments
10 OPIOIDS DRUG MARKET FORECAST BY REGION
10.1 Global Opioids Drug Market Size Forecast
10.2 Global Opioids Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Opioids Drug Market Size Forecast by Country
10.2.3 Asia Pacific Opioids Drug Market Size Forecast by Region
10.2.4 South America Opioids Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Opioids Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Opioids Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Opioids Drug by Type (2025-2030)
11.1.2 Global Opioids Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Opioids Drug by Type (2025-2030)
11.2 Global Opioids Drug Market Forecast by Application (2025-2030)
11.2.1 Global Opioids Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Opioids Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Opioids Drug
1.2 Key Market Segments
1.2.1 Opioids Drug Segment by Type
1.2.2 Opioids Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OPIOIDS DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Opioids Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Opioids Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OPIOIDS DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Opioids Drug Sales by Manufacturers (2019-2024)
3.2 Global Opioids Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Opioids Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Opioids Drug Sales Sites, Area Served, Product Type
3.6 Opioids Drug Market Competitive Situation and Trends
3.6.1 Opioids Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Opioids Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OPIOIDS DRUG INDUSTRY CHAIN ANALYSIS
4.1 Opioids Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OPIOIDS DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OPIOIDS DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioids Drug Sales Market Share by Type (2019-2024)
6.3 Global Opioids Drug Market Size Market Share by Type (2019-2024)
6.4 Global Opioids Drug Price by Type (2019-2024)
7 OPIOIDS DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioids Drug Market Sales by Application (2019-2024)
7.3 Global Opioids Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Opioids Drug Sales Growth Rate by Application (2019-2024)
8 OPIOIDS DRUG MARKET SEGMENTATION BY REGION
8.1 Global Opioids Drug Sales by Region
8.1.1 Global Opioids Drug Sales by Region
8.1.2 Global Opioids Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Opioids Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Opioids Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Opioids Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Opioids Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Opioids Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva
9.1.1 Teva Opioids Drug Basic Information
9.1.2 Teva Opioids Drug Product Overview
9.1.3 Teva Opioids Drug Product Market Performance
9.1.4 Teva Business Overview
9.1.5 Teva Opioids Drug SWOT Analysis
9.1.6 Teva Recent Developments
9.2 Purdue Pharma
9.2.1 Purdue Pharma Opioids Drug Basic Information
9.2.2 Purdue Pharma Opioids Drug Product Overview
9.2.3 Purdue Pharma Opioids Drug Product Market Performance
9.2.4 Purdue Pharma Business Overview
9.2.5 Purdue Pharma Opioids Drug SWOT Analysis
9.2.6 Purdue Pharma Recent Developments
9.3 Mallinckrodt
9.3.1 Mallinckrodt Opioids Drug Basic Information
9.3.2 Mallinckrodt Opioids Drug Product Overview
9.3.3 Mallinckrodt Opioids Drug Product Market Performance
9.3.4 Mallinckrodt Opioids Drug SWOT Analysis
9.3.5 Mallinckrodt Business Overview
9.3.6 Mallinckrodt Recent Developments
9.4 Amneal Pharma
9.4.1 Amneal Pharma Opioids Drug Basic Information
9.4.2 Amneal Pharma Opioids Drug Product Overview
9.4.3 Amneal Pharma Opioids Drug Product Market Performance
9.4.4 Amneal Pharma Business Overview
9.4.5 Amneal Pharma Recent Developments
9.5 Collegium
9.5.1 Collegium Opioids Drug Basic Information
9.5.2 Collegium Opioids Drug Product Overview
9.5.3 Collegium Opioids Drug Product Market Performance
9.5.4 Collegium Business Overview
9.5.5 Collegium Recent Developments
9.6 JandJ
9.6.1 JandJ Opioids Drug Basic Information
9.6.2 JandJ Opioids Drug Product Overview
9.6.3 JandJ Opioids Drug Product Market Performance
9.6.4 JandJ Business Overview
9.6.5 JandJ Recent Developments
9.7 Endo
9.7.1 Endo Opioids Drug Basic Information
9.7.2 Endo Opioids Drug Product Overview
9.7.3 Endo Opioids Drug Product Market Performance
9.7.4 Endo Business Overview
9.7.5 Endo Recent Developments
9.8 Pfizer
9.8.1 Pfizer Opioids Drug Basic Information
9.8.2 Pfizer Opioids Drug Product Overview
9.8.3 Pfizer Opioids Drug Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 INSYS
9.9.1 INSYS Opioids Drug Basic Information
9.9.2 INSYS Opioids Drug Product Overview
9.9.3 INSYS Opioids Drug Product Market Performance
9.9.4 INSYS Business Overview
9.9.5 INSYS Recent Developments
9.10 Mylan
9.10.1 Mylan Opioids Drug Basic Information
9.10.2 Mylan Opioids Drug Product Overview
9.10.3 Mylan Opioids Drug Product Market Performance
9.10.4 Mylan Business Overview
9.10.5 Mylan Recent Developments
9.11 Hikma
9.11.1 Hikma Opioids Drug Basic Information
9.11.2 Hikma Opioids Drug Product Overview
9.11.3 Hikma Opioids Drug Product Market Performance
9.11.4 Hikma Business Overview
9.11.5 Hikma Recent Developments
9.12 Egalet
9.12.1 Egalet Opioids Drug Basic Information
9.12.2 Egalet Opioids Drug Product Overview
9.12.3 Egalet Opioids Drug Product Market Performance
9.12.4 Egalet Business Overview
9.12.5 Egalet Recent Developments
10 OPIOIDS DRUG MARKET FORECAST BY REGION
10.1 Global Opioids Drug Market Size Forecast
10.2 Global Opioids Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Opioids Drug Market Size Forecast by Country
10.2.3 Asia Pacific Opioids Drug Market Size Forecast by Region
10.2.4 South America Opioids Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Opioids Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Opioids Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Opioids Drug by Type (2025-2030)
11.1.2 Global Opioids Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Opioids Drug by Type (2025-2030)
11.2 Global Opioids Drug Market Forecast by Application (2025-2030)
11.2.1 Global Opioids Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Opioids Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Opioids Drug Market Size Comparison by Region (M USD)
Table 5. Global Opioids Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Opioids Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Opioids Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Opioids Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Drug as of 2022)
Table 10. Global Market Opioids Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Opioids Drug Sales Sites and Area Served
Table 12. Manufacturers Opioids Drug Product Type
Table 13. Global Opioids Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Opioids Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioids Drug Market Challenges
Table 22. Global Opioids Drug Sales by Type (Kilotons)
Table 23. Global Opioids Drug Market Size by Type (M USD)
Table 24. Global Opioids Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Opioids Drug Sales Market Share by Type (2019-2024)
Table 26. Global Opioids Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Opioids Drug Market Size Share by Type (2019-2024)
Table 28. Global Opioids Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Opioids Drug Sales (Kilotons) by Application
Table 30. Global Opioids Drug Market Size by Application
Table 31. Global Opioids Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Opioids Drug Sales Market Share by Application (2019-2024)
Table 33. Global Opioids Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Opioids Drug Market Share by Application (2019-2024)
Table 35. Global Opioids Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Opioids Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Opioids Drug Sales Market Share by Region (2019-2024)
Table 38. North America Opioids Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Opioids Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Opioids Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Opioids Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Opioids Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Teva Opioids Drug Basic Information
Table 44. Teva Opioids Drug Product Overview
Table 45. Teva Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Teva Business Overview
Table 47. Teva Opioids Drug SWOT Analysis
Table 48. Teva Recent Developments
Table 49. Purdue Pharma Opioids Drug Basic Information
Table 50. Purdue Pharma Opioids Drug Product Overview
Table 51. Purdue Pharma Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Purdue Pharma Business Overview
Table 53. Purdue Pharma Opioids Drug SWOT Analysis
Table 54. Purdue Pharma Recent Developments
Table 55. Mallinckrodt Opioids Drug Basic Information
Table 56. Mallinckrodt Opioids Drug Product Overview
Table 57. Mallinckrodt Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Mallinckrodt Opioids Drug SWOT Analysis
Table 59. Mallinckrodt Business Overview
Table 60. Mallinckrodt Recent Developments
Table 61. Amneal Pharma Opioids Drug Basic Information
Table 62. Amneal Pharma Opioids Drug Product Overview
Table 63. Amneal Pharma Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Amneal Pharma Business Overview
Table 65. Amneal Pharma Recent Developments
Table 66. Collegium Opioids Drug Basic Information
Table 67. Collegium Opioids Drug Product Overview
Table 68. Collegium Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Collegium Business Overview
Table 70. Collegium Recent Developments
Table 71. JandJ Opioids Drug Basic Information
Table 72. JandJ Opioids Drug Product Overview
Table 73. JandJ Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. JandJ Business Overview
Table 75. JandJ Recent Developments
Table 76. Endo Opioids Drug Basic Information
Table 77. Endo Opioids Drug Product Overview
Table 78. Endo Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Endo Business Overview
Table 80. Endo Recent Developments
Table 81. Pfizer Opioids Drug Basic Information
Table 82. Pfizer Opioids Drug Product Overview
Table 83. Pfizer Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Pfizer Business Overview
Table 85. Pfizer Recent Developments
Table 86. INSYS Opioids Drug Basic Information
Table 87. INSYS Opioids Drug Product Overview
Table 88. INSYS Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. INSYS Business Overview
Table 90. INSYS Recent Developments
Table 91. Mylan Opioids Drug Basic Information
Table 92. Mylan Opioids Drug Product Overview
Table 93. Mylan Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Mylan Business Overview
Table 95. Mylan Recent Developments
Table 96. Hikma Opioids Drug Basic Information
Table 97. Hikma Opioids Drug Product Overview
Table 98. Hikma Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hikma Business Overview
Table 100. Hikma Recent Developments
Table 101. Egalet Opioids Drug Basic Information
Table 102. Egalet Opioids Drug Product Overview
Table 103. Egalet Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Egalet Business Overview
Table 105. Egalet Recent Developments
Table 106. Global Opioids Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Opioids Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Opioids Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Opioids Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Opioids Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Opioids Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Opioids Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Opioids Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Opioids Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Opioids Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Opioids Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Opioids Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Opioids Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Opioids Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Opioids Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Opioids Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Opioids Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Opioids Drug Market Size Comparison by Region (M USD)
Table 5. Global Opioids Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Opioids Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Opioids Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Opioids Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Drug as of 2022)
Table 10. Global Market Opioids Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Opioids Drug Sales Sites and Area Served
Table 12. Manufacturers Opioids Drug Product Type
Table 13. Global Opioids Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Opioids Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioids Drug Market Challenges
Table 22. Global Opioids Drug Sales by Type (Kilotons)
Table 23. Global Opioids Drug Market Size by Type (M USD)
Table 24. Global Opioids Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Opioids Drug Sales Market Share by Type (2019-2024)
Table 26. Global Opioids Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Opioids Drug Market Size Share by Type (2019-2024)
Table 28. Global Opioids Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Opioids Drug Sales (Kilotons) by Application
Table 30. Global Opioids Drug Market Size by Application
Table 31. Global Opioids Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Opioids Drug Sales Market Share by Application (2019-2024)
Table 33. Global Opioids Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Opioids Drug Market Share by Application (2019-2024)
Table 35. Global Opioids Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Opioids Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Opioids Drug Sales Market Share by Region (2019-2024)
Table 38. North America Opioids Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Opioids Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Opioids Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Opioids Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Opioids Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Teva Opioids Drug Basic Information
Table 44. Teva Opioids Drug Product Overview
Table 45. Teva Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Teva Business Overview
Table 47. Teva Opioids Drug SWOT Analysis
Table 48. Teva Recent Developments
Table 49. Purdue Pharma Opioids Drug Basic Information
Table 50. Purdue Pharma Opioids Drug Product Overview
Table 51. Purdue Pharma Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Purdue Pharma Business Overview
Table 53. Purdue Pharma Opioids Drug SWOT Analysis
Table 54. Purdue Pharma Recent Developments
Table 55. Mallinckrodt Opioids Drug Basic Information
Table 56. Mallinckrodt Opioids Drug Product Overview
Table 57. Mallinckrodt Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Mallinckrodt Opioids Drug SWOT Analysis
Table 59. Mallinckrodt Business Overview
Table 60. Mallinckrodt Recent Developments
Table 61. Amneal Pharma Opioids Drug Basic Information
Table 62. Amneal Pharma Opioids Drug Product Overview
Table 63. Amneal Pharma Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Amneal Pharma Business Overview
Table 65. Amneal Pharma Recent Developments
Table 66. Collegium Opioids Drug Basic Information
Table 67. Collegium Opioids Drug Product Overview
Table 68. Collegium Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Collegium Business Overview
Table 70. Collegium Recent Developments
Table 71. JandJ Opioids Drug Basic Information
Table 72. JandJ Opioids Drug Product Overview
Table 73. JandJ Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. JandJ Business Overview
Table 75. JandJ Recent Developments
Table 76. Endo Opioids Drug Basic Information
Table 77. Endo Opioids Drug Product Overview
Table 78. Endo Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Endo Business Overview
Table 80. Endo Recent Developments
Table 81. Pfizer Opioids Drug Basic Information
Table 82. Pfizer Opioids Drug Product Overview
Table 83. Pfizer Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Pfizer Business Overview
Table 85. Pfizer Recent Developments
Table 86. INSYS Opioids Drug Basic Information
Table 87. INSYS Opioids Drug Product Overview
Table 88. INSYS Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. INSYS Business Overview
Table 90. INSYS Recent Developments
Table 91. Mylan Opioids Drug Basic Information
Table 92. Mylan Opioids Drug Product Overview
Table 93. Mylan Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Mylan Business Overview
Table 95. Mylan Recent Developments
Table 96. Hikma Opioids Drug Basic Information
Table 97. Hikma Opioids Drug Product Overview
Table 98. Hikma Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hikma Business Overview
Table 100. Hikma Recent Developments
Table 101. Egalet Opioids Drug Basic Information
Table 102. Egalet Opioids Drug Product Overview
Table 103. Egalet Opioids Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Egalet Business Overview
Table 105. Egalet Recent Developments
Table 106. Global Opioids Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Opioids Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Opioids Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Opioids Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Opioids Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Opioids Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Opioids Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Opioids Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Opioids Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Opioids Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Opioids Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Opioids Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Opioids Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Opioids Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Opioids Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Opioids Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Opioids Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Opioids Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioids Drug Market Size (M USD), 2019-2030
Figure 5. Global Opioids Drug Market Size (M USD) (2019-2030)
Figure 6. Global Opioids Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioids Drug Market Size by Country (M USD)
Figure 11. Opioids Drug Sales Share by Manufacturers in 2023
Figure 12. Global Opioids Drug Revenue Share by Manufacturers in 2023
Figure 13. Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Opioids Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Opioids Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Opioids Drug Market Share by Type
Figure 18. Sales Market Share of Opioids Drug by Type (2019-2024)
Figure 19. Sales Market Share of Opioids Drug by Type in 2023
Figure 20. Market Size Share of Opioids Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Opioids Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Opioids Drug Market Share by Application
Figure 24. Global Opioids Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Opioids Drug Sales Market Share by Application in 2023
Figure 26. Global Opioids Drug Market Share by Application (2019-2024)
Figure 27. Global Opioids Drug Market Share by Application in 2023
Figure 28. Global Opioids Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Opioids Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Opioids Drug Sales Market Share by Country in 2023
Figure 32. U.S. Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Opioids Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Opioids Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Opioids Drug Sales Market Share by Country in 2023
Figure 37. Germany Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Opioids Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Opioids Drug Sales Market Share by Region in 2023
Figure 44. China Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Opioids Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Opioids Drug Sales Market Share by Country in 2023
Figure 51. Brazil Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Opioids Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Opioids Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Opioids Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Opioids Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Opioids Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Opioids Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Opioids Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Opioids Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Opioids Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioids Drug Market Size (M USD), 2019-2030
Figure 5. Global Opioids Drug Market Size (M USD) (2019-2030)
Figure 6. Global Opioids Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioids Drug Market Size by Country (M USD)
Figure 11. Opioids Drug Sales Share by Manufacturers in 2023
Figure 12. Global Opioids Drug Revenue Share by Manufacturers in 2023
Figure 13. Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Opioids Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Opioids Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Opioids Drug Market Share by Type
Figure 18. Sales Market Share of Opioids Drug by Type (2019-2024)
Figure 19. Sales Market Share of Opioids Drug by Type in 2023
Figure 20. Market Size Share of Opioids Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Opioids Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Opioids Drug Market Share by Application
Figure 24. Global Opioids Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Opioids Drug Sales Market Share by Application in 2023
Figure 26. Global Opioids Drug Market Share by Application (2019-2024)
Figure 27. Global Opioids Drug Market Share by Application in 2023
Figure 28. Global Opioids Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Opioids Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Opioids Drug Sales Market Share by Country in 2023
Figure 32. U.S. Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Opioids Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Opioids Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Opioids Drug Sales Market Share by Country in 2023
Figure 37. Germany Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Opioids Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Opioids Drug Sales Market Share by Region in 2023
Figure 44. China Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Opioids Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Opioids Drug Sales Market Share by Country in 2023
Figure 51. Brazil Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Opioids Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Opioids Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Opioids Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Opioids Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Opioids Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Opioids Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Opioids Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Opioids Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Opioids Drug Market Share Forecast by Application (2025-2030)